This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Open Angle Glaucoma or Ocular Hypertension
and you are
over 18
years old
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

To demonstrate superiority of DuoTrav APS over XALACOM® in Ocular Surface Health in patients with open angle glaucoma or ocular hypertension.

Provided treatments

  • Drug: DuoTrav APS
  • Drug: Xalacom
Tris trial is registered with FDA with number: NCT00912054. The sponsor of the trial is Alcon Research and it is looking for 240 volunteers for the current phase.
Official trial title: